Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%EURPLN0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.63%ETHUSD+71.01%USDTUSD+0.12%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.07%XMRUSDT-1.90%DOGEUSD+69.80%LINKUSD+1.97%XLMUSD-0.51%BCHUSDT-1.05%LTCUSD+68.40%UNIUSD-1.26%TONUSD+79.92%SUIUSD+1.12%HBARUSDT-0.18%TAOUSDT+2.25%AAVEUSD+0.67%ONDOUSDT+0.38%DOTUSDT+0.69%ICPUSDT+1.11%WLDUSDT+2.01%ARBUSDT+0.81%ATOMUSDT+0.70%INJUSDT+4.22%STXUSDT+2.19%PYTHUSDT+1.23%TIAUSDT+3.05%FETUSDT-0.13%SEIUSDT+0.59%JUPUSDT+0.03%GRTUSDT+0.51%OPUSDT+1.55%IOTAUSDT+1.62%POLUSDT-0.35%WIFUSDT+1.51%AXSUSDT-0.31%EOSUSDT+0.14%IMXUSDT+0.09%FARTCOINUSDT+0.76%GALAUSDT+2.69%DYDXUSDT+0.39%ORDIUSDT+1.89%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%EURPLN0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.63%ETHUSD+71.01%USDTUSD+0.12%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.07%XMRUSDT-1.90%DOGEUSD+69.80%LINKUSD+1.97%XLMUSD-0.51%BCHUSDT-1.05%LTCUSD+68.40%UNIUSD-1.26%TONUSD+79.92%SUIUSD+1.12%HBARUSDT-0.18%TAOUSDT+2.25%AAVEUSD+0.67%ONDOUSDT+0.38%DOTUSDT+0.69%ICPUSDT+1.11%WLDUSDT+2.01%ARBUSDT+0.81%ATOMUSDT+0.70%INJUSDT+4.22%STXUSDT+2.19%PYTHUSDT+1.23%TIAUSDT+3.05%FETUSDT-0.13%SEIUSDT+0.59%JUPUSDT+0.03%GRTUSDT+0.51%OPUSDT+1.55%IOTAUSDT+1.62%POLUSDT-0.35%WIFUSDT+1.51%AXSUSDT-0.31%EOSUSDT+0.14%IMXUSDT+0.09%FARTCOINUSDT+0.76%GALAUSDT+2.69%DYDXUSDT+0.39%ORDIUSDT+1.89%NOTUSDT+1.19%RONINUSDT+1.91%
AL

Abbott Laboratories (ABT)

NYSE • Healthcare

$103
-$0.87 (-0.8%)
Market closed

November 20, 2026 at 21:00 UTC

Open$104.32
Day Range$102.8 - $105.5
Avg. Volume (3M)8M
Market Cap$178.3B
P/E Ratio38.1
52 Week Range
$81.97$129.85
Next EarningsIn 67 daysJan 28, 2027

Interactive Chart

12:43:27 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$13B100%
Gross Profitminus cost of goods$7.3B57%
Operating Incomeminus R&D and overhead$1.3B10%
Net Incomeminus taxes and the rest$920M7%

In plain terms: out of every $100 in revenue, Abbott Laboratories keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$48.2B
Net Income (TTM)
$4.7B
EPS (TTM)
$2.7
ROA (TTM)
4.34%
Current Ratio
1.45
Dividend Yield
0.64%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+0.9%Q2 2026$1.15
+2.3%Q3 2026$1.31
0.0%Q4 2026$1.42
Next

Jan 28

in 67 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Met

Abbott Laboratories’ revenue rose 14.5% to about $13.0 billion in the third fiscal quarter of 2026 (period ended September 30, 2026), with results reported October 21, 2026 based on preliminary figures; adjusted EPS of $1.42 came in line with the $1.42 estimate, and revenue of $13.013 billion was in line with the $12.989 billion estimate (+0.2%). The top line was up from about $11.4 billion a year ago, while profitability showed gross margin at roughly 57% and operating margin near 11% as gross profit was about $7.4 billion and operating income around $1.5 billion across the company’s mix of medical devices, diagnostics, nutrition, and established pharmaceuticals. Net income fell 44.0% year over year to roughly $920 million, down from about $1.6 billion a year ago, even as adjusted EPS increased 9.2% from $1.30. For the next period, consensus calls for EPS of $1.65 on revenue of $13.257 billion.

View full earnings history

About Abbott Laboratories

Abbott Laboratories (NYSE: ABT) is a healthcare company centered on medical devices, diagnostics, nutrition, and branded generic medications sold through worldwide distribution, with operations that reach global markets. Across these businesses, Abbott generated $44.3 billion of revenue in FY2025, spanning products used in testing, chronic disease management, and everyday nutritional care.

Name
Abbott Laboratories
CEO
Robert Ford
Industry
Healthcare
Year Founded
1888
Employees
115,000

Today's Snapshot

AI-generated

ABT closed 0.7% below yesterday's close, while its sector was flat. Volume was about two-thirds of its usual level. Leerink, a stock research firm, upgraded Abbott Laboratories to Outperform.

Trading Volume

Below 10d avg (7.5M)

5.1M

vs S&P 500 Today

Outperforming Market

+2.84%

Updated: November 20, 2026 at 21:09 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
ABT presents a mixed technical picture with the current price a bit below short- and medium-term averages but close to the 200-day simple average, leaving longer-term context ambiguous. Momentum indicators are muted: RSI and MACD offer no strong read while stochastic shows an oversold buy signal and short-term momentum is negative. ADX is low, pointing to a lack of directional conviction, and ATR is moderate, suggesting limited intraday variation. OBV is markedly negative, indicating distribution pressure that undermines recovery attempts; the classic pivot sits slightly above the market. Technical takeaway: Neutral — short-term weakness met by long-term support and poor volume leaves the setup unresolved.
All signals
  • EMA (5 indicators)$104.25 - $106.33
    Sell
  • RSI (14)41.89
    Neutral
  • Stochastic %K (14, 3, 3)4.88
    Buy
  • MACD Level (12, 26)0.11
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.